Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Blood samples will be tested by Natera to identify residual tumor DNA for genetic changes in the tumor to potentially improve prediction of long term prognosis and guide treatment options.
Age
18–95
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of epithelial ovarian cancer stage II-IV
You may not be if
Insufficient tumor to perform Signatera testing; Inability to provide consent for the trial
